Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IAM-1363 by Iambic Therapeutics for Solid Tumor: Likelihood of Approval
IAM-1363 is under clinical development by Iambic Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
IAM-1363 by Iambic Therapeutics for Colorectal Cancer: Likelihood of Approval
IAM-1363 is under clinical development by Iambic Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
IAM-1363 by Iambic Therapeutics for Bladder Cancer: Likelihood of Approval
IAM-1363 is under clinical development by Iambic Therapeutics and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...
IAM-1363 by Iambic Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
IAM-1363 is under clinical development by Iambic Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
IAM-1363 by Iambic Therapeutics for Breast Cancer: Likelihood of Approval
IAM-1363 is under clinical development by Iambic Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...